Literature DB >> 25201723

Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis.

Philip A Linden1, Thomas A D'Amico2, Yaron Perry3, Paramita Saha-Chaudhuri4, Shubin Sheng4, Sunghee Kim4, Mark Onaitis2.   

Abstract

BACKGROUND: Wedge resection is often used instead of anatomic resection in an attempt to mitigate perioperative risk. In propensity-matched populations, we sought to compare the perioperative outcomes of patients undergoing wedge resection with those undergoing anatomic resection.
METHODS: The Society of Thoracic Surgery database was reviewed for stage I and II non-small cell lung cancer patients undergoing wedge resection and anatomic resection to analyze postoperative morbidity and mortality. Propensity scores were estimated using a logistic model adjusted for a variety of risk factors. Patients were then matched by propensity score using a greedy 5- to 1-digit matching algorithm, and compared using McNemar's test.
RESULTS: Between 2009 and 2011, 3,733 wedge resection and 3,733 anatomic resection patients were matched. The operative mortality was 1.21% for wedge resection versus 1.93% for anatomic resection (p=0.0118). Major morbidity occurred in 4.53% of wedge resection patients versus 8.97% of anatomic resection patients (p<0.0001). A reduction was noted in the incidence of pulmonary complications, but not cardiovascular or neurologic complications. There was a consistent reduction in major morbidity regardless of age, lung function, or type of incision. Mortality was reduced in patients with preoperative forced expiratory volume in 1 second less than 85% predicted.
CONCLUSIONS: Wedge resection has a 37% lower mortality and 50% lower major morbidity rate than anatomic resection in these propensity-matched populations. The mortality benefit is most apparent in patients with forced expiratory volume in 1 second less than 85% predicted. These perioperative benefits must be carefully weighed against the increase in locoregional recurrence and possible decrease in long-term survival associated with the use of wedge resection for primary lung cancers.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25201723     DOI: 10.1016/j.athoracsur.2014.06.017

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials.

Authors:  Chi-Fu Jeffrey Yang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-05       Impact factor: 5.209

2.  Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Akikazu Kawase; Nobumasa Takahashi; Takeshi Kawaguchi; Tetsukan Woo; Yuichi Saito; Satoshi Shiono; Noriyuki Matsutani
Journal:  Surg Today       Date:  2018-06-19       Impact factor: 2.549

3.  A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.

Authors:  Brian C Gulack; Chi-Fu Jeffrey Yang; Paul J Speicher; Babatunde A Yerokun; Betty C Tong; Mark W Onaitis; Thomas A D'Amico; David H Harpole; Matthew G Hartwig; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2016-09-01       Impact factor: 4.330

Review 4.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases.

Authors:  Michelle C Salazar; Maureen E Canavan; Samantha L Walters; Sitaram Chilakamarry; Theresa Ermer; Justin D Blasberg; James B Yu; Cary P Gross; Daniel J Boffa
Journal:  JTO Clin Res Rep       Date:  2021-01-21

Review 6.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

7.  Postoperative atrial fibrillation prophylaxis using a novel amiodarone order set.

Authors:  Joseph D Phillips; Eleah D Porter; Brendin R Beaulieu-Jones; Kayla A Fay; Rian M Hasson; Timothy M Millington; David J Finley
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.